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Background: The stratified model of care has been an effective approach for the treatment of low back pain.
However, the treatment of patients with low risk of psychosocial-factor involvement is unclear. The addition of the
therapeutic alliance to a minimal intervention may be an option for the treatment of low back pain. This paper
reports on the rationale, design and protocol for a randomized controlled trial with blind assessor to assess the
effectiveness of the addition of therapeutic alliance with minimal intervention on pain and disability in patients
with chronic, nonspecific low back pain.
Methods: Two hundred and twenty-two patients with chronic, nonspecific low back pain and low risk of
involvement of psychosocial factors will be assessed and randomly allocated into three groups (n = 74 patients per
group). The Positive Therapeutic Alliance group will receive counseling and guidance with an emphasis on
therapeutic alliance and empathy. The Usual Treatment group will receive the same information and counseling
with limited interaction with the therapist. The Control group will not receive any intervention. The treatment will
be composed by two intervention sessions with a 1-week interval. A blinded assessor will collect the following
outcomes at baseline, 1 month, 6 months and 12 months after randomization: pain intensity (Pain Numerical Rating
Scale), specific disability (Patient-specific Functional Scale), general disability (Oswestry Disability Index), global
perceived effect (Global Perceived Effect Scale), empathy (Consultation and Relational Empathy Measure), credibility
and expectations related to treatment. The analysis will be performed using linear mixed models.
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Discussion: This will be the first study to understand the effect of combining enhanced therapeutic alliance to a
treatment based on counseling, information and advice (minimal intervention). The addition of the therapeutic
alliance to minimal intervention may improve the treatment of chronic, nonspecific low back pain.
Trial registration: ClinicalTrials.gov, NCT 02497625. Registered on 10 July 2015.
Keywords: Low back pain, Empathy, Subgroups, Minimal interventionBackground
Low back pain remains a global public health problem [1].
It is considered to be the sixth leading cause of disability-
adjusted life years among more than 200 health conditions
[1, 2]. Despite the increase in quantity and quality of re-
search in recent decades, the available treatments for low
back pain tend to produce minor or moderate effects.
These effects are positive in the short term and only some
of them maintain long-term improvements [3]. The high
prevalence of low back pain makes impossible the use of
treatment strategies that demand high resources for all pa-
tients [4]. Studies have shown that a small group of pa-
tients who develop chronic pain are responsible for most
of the treatment-related costs [5, 6]. Thus, it is important
to identify patients who would benefit from a specific
treatment from those who would show little benefit or
even worsening of symptoms [4].
Low back pain is an ideal condition for the stratification
of treatment subgroups since it is a condition that affects
a heterogeneous population, presenting prognostic vari-
ation and relying on different diagnostic options and avail-
able treatments [4, 7, 8]. Stratification based on the
prognosis of the clinical condition is a form of classifying
low-back-pain patients in subgroups and it is based on the
risk of developing persistent pain and disability related to
psychosocial factors [4]. Psychosocial factors (e.g., depres-
sion, stress, aspects related to work and fear of movement
[9]) are predictive for the occurrence of new episodes and
the long-term persistence of pain and disability [8, 10–12].
Treatment in subgroups may also facilitate the clinical
decision-making process and guide appropriate treatment
for these patients [4]. Moreover, it may assist therapeutic
decision-making, maximize treatment benefits, reduce
risks and increase health system efficiency [8, 13].
Recent studies have shown the cost-effectiveness of the
treatment based on the chronic low back pain prognosis
in patients with high and medium risks of developing
chronic problems related to psychosocial factors [8, 14].
Positive results were associated with decreased pain and
disability, in addition to reduction in cost and work absen-
teeism [7, 14]. However, the results of a recent random-
ized controlled trial showed no significant differences for
patients with low-risk of involvement of psychosocial fac-
tors when compared the usual treatment and targetedtreatment based on subgroups [15]. These negative results
may be explained by the fact that patients already pre-
sented low levels of pain and disability and by the use of
questionnaires with low responsiveness for low-risk pa-
tients [16]. Disability questionnaires frequently used to
evaluate patients with low back pain are not sensible to
detect a clinical change in patients with low level of dis-
ability. For this kind of patients, it is recommended to use
specific questionnaires of disability [16]. In the treatment
of these low-risk patients it is recommended that informa-
tion and guidance be provided on correct diagnosis, prog-
nosis, symptoms, physical activity levels, return to work
and disease severity, preferably at the first contact with
the health professional [9, 17, 18]. Considering the good
prognosis of low-risk patients, some studies suggest a
minimal intervention approach (counseling sessions and
positive information) [7, 17]. This approach might be a
quick and low-cost treatment option to the health system.
Furthermore, identifying appropriate treatment for each
patient may prevent the unnecessary use of expensive or
extended resources [4]. There is also the possibility of re-
ducing the use of diagnostic procedures (imaging tests, for
example), decreasing the number of consultations during
the recovery process and consequently less use of finan-
cial resources. Thus, some studies emphasize the need
to develop more effective treatment strategies for this
patient subgroup [7, 8, 14]. One of the possibilities of
the nonsignificant results deriving from minimal inter-
vention with these patients is that patients with low risk
of developing chronic problems have low to medium
levels of pain and disability. Therefore, it is necessary to
evaluate patients using measurement instruments that
are more responsive to this clinical condition [16].
The extent of treatment effectiveness may be influenced
by factors other than the intervention chosen. Contextual
factors comprise the therapeutic effect of any intervention.
These factors consist of a complex interaction between
technical and communicative knowledge in addition to the
therapist’s ability to meet the expectations of the patient
during treatment [19]. Studies have shown that a good rela-
tionship between the therapist and patient is related to de-
creased pain level and disability as well as improved
satisfaction with treatment [20, 21]. The therapeutic alli-
ance may be defined as harmony or social connection
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nitude and extent of this association in musculoskeletal pa-
tients are unknown [21]. This gap in the medical literature
reinforces the need for studies on this subject, especially in
the treatment of patients with musculoskeletal complaints.
Emerging evidence indicates that the degree and quality of
the interaction between clinician and patient is important
because it influences the magnitude of the active treatment,
as well as the degree of placebo effect [21, 23, 24]. Although
therapeutic alliance has been shown to produce thera-
peutic benefits in some areas, such as medicine and
psychotherapy, there is little empirical support yet for
this subject in physiotherapy [20, 21]. A recent system-
atic review showed a consistent pattern of positive
therapeutic alliance correlated with improved pain,
disability and treatment satisfaction in physical reha-
bilitation [21].
A recent study investigated the effects of increased
therapeutic alliance and empathy in the treatment of pa-
tients with low back pain receiving active interferential
current or a placebo. Patients were randomly allocated
into four groups: (1) limited interaction plus active
current, (2) limited interaction plus placebo, (3) in-
creased interaction plus active current and (4) increased
interaction plus placebo. The results showed clinical im-
provement associated with increased interaction be-
tween therapist and patient, which remained even with
the application of placebo [25]. This study evaluated the
effects only in the short term and did not classify pa-
tients into specific treatment subgroups. Therefore, the
rationale of this study is based on emerging evidence of
the importance of the therapeutic alliance in the clinical
context [19, 21, 23–29].
Appropriate treatment for low-risk patients can pro-
vide important clinical benefits. It could be a fast and
low-cost treatment option for the health system since it
would help in identifying patients who do not require
unnecessary or extensive assessment and treatment [4].
To date, there are no studies that have investigated the
therapeutic alliance combined with minimal intervention
in the treatment of patients with chronic, nonspecific
low back pain and low risk of psychosocial-factor in-
volvement. Therefore, the objective of this study is to
evaluate the effectiveness of the addition of the thera-
peutic alliance with minimal intervention in the treat-
ment of patients with chronic, nonspecific low back
pain with a low risk of having psychosocial-factor in-
volvement in their pain, specific and general disability,
global perceived effect, empathy, credibility and expect-
ation. The hypothesis of this study is that there will be
a clinical benefit in pain, and especially in specific
disability, 1 month after randomization into the group
receiving treatment with the addition of the therapeutic
alliance.Methods
Study design
This is a three-arm randomized controlled trial with
blinded assessor. The patients will be divided into three
groups: a Positive Therapeutic Alliance (PTA) group, a
Usual Treatment (UT) group and a Control group (CG).
Table 1 details the study timeline and follows the style of
the Standard Protocol Items: Recommendations for Inter-
ventional Trial (SPIRIT) guideline. The SPIRIT Checklist
and figure for the study protocol are provided as Additional
file 1 and Additional file 2. The World Health Organization
Trial Registration Data Set is provided as Additional file 3.
Sample size calculation
The sample size calculation was carried out to detect a
difference of 1 point on the Pain Numerical Rating Scale
(estimated standard deviation = 1.84) and 1 point on the
Patient-specific Functional Scale (estimated standard de-
viation = 1.8). The calculations were performed consider-
ing an α = 0.05, a statistical power of 80% and a follow-
up loss of 15%. Thus, this study will comprise a sample
of 222 patients who will be divided into three treatment
groups (n = 74 patients per group).
Eligibility criteria
This study will be carried out with patients on the treat-
ment waiting lists of two physical therapy teaching clinics
in the city of Taubaté, São Paulo (approved by the Ethics
Committee of Universidade Bandeirante Anhanguera n.
44720315.5.0000.5372). The patients will be invited per-
sonally by phone. This study will include patients who
have had chronic, nonspecific low back pain for at least
3 months, aged between 18 and 80 years, and who are able
to read and write in Portuguese and classified as low risk
of having psychosocial factors involved [8] according to
the Start Back Screening Tool (SBST-Brazil) questionnaire
[30, 31]. Patients with a history of spinal surgery, serious
spinal diseases, nerve root compromise, diseases associ-
ated with cognitive impairment confirmed by medical
diagnosis, or pregnancy will be excluded.
Procedures
Patients will be evaluated by a previously trained blinded
assessor who will provide information on the procedures
and criteria for study participation. The assessor will
contact patients by phone to confirm their eligibility cri-
teria and to fill out the SBST-Brazil questionnaire. In the
case of acceptance of participation and compliance with
the eligibility criteria, the patient will be forwarded to
initial assessment.
The blinded assessor will collect data at the baseline
utilizing a neutral communication style so as not to in-
fluence the therapeutic alliance involved in patient care.
A coding system in follow-up assessments will be carried
Table 1 Timeline for the schedule of enrollment, interventions and assessments

















Pain intensity X X
Specific disability X X
Secondary outcomes
Pain intensity X X
Specific disability X X
General disability X X X X
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gible patients will be referred to the therapist responsible
for the interventions. An independent researcher not in-
volved in the recruitment and evaluation of patients will
perform randomization using Microsoft Excel software
random number generation. The secret allocation will
be made using sequential, numbered, sealed opaque en-
velopes. Due to the nature of the study, it will not be
possible to blind the therapist or patients. All re-
searchers involved in the stages of this study will receive
adequate training to carry out the activities. Patient re-
cruitment will begin in September 2015 and the date of
completion will be December 2016.
Assessments
The elegibility criteria, collection of demographic and
anthropometric data from the patients as well the out-
comes will be conducted by a blinded assessor. The
randomization to the treatments groups will be done be-
fore the initial evaluation. The assessor will be aware of
the allocation only after data analysis.
All the questionnaires and scales used to assess pri-
mary and secondary outcomes have been translated and
adapted into Brazilian-Portuguese and have shown ad-
equate measurement properties. The primary outcomes
of this study will be pain and specific disability after1 month of randomization. The study’s secondary out-
comes will be pain and specific disability 6 and
12 months after randomization; and general disability
and perceived global effect 1, 6 and 12 months after
randomization. Empathy, credibility and expectations re-
lated to treatment will be used as additional outcomes.
Demographic characteristics
The initial assessment information will include age, gen-
der, height, weight, educational level and job information
related to low back pain (pain location, duration, use of
medication and previous treatments).
STarT Back Screening Tool
The SBST-Brazil questionnaire is a prognostic evaluation
tool which aims to classify patients into low, medium or
high risk of developing long-term pain or disability re-
lated to psychosocial factors [30, 31]. The questionnaire
contains questions related to pain, disability, comorbidi-
ties, bothersomeness, pain catastrophizing, fear, anxiety
and depression. For scoring and classification, the pa-
tient must choose between “agree” (1 point) or “dis-
agree” (0 points) on the first eight questions. Question 9
contains five possible answers: not at all (0 points),
slightly (0 points), moderately (0 point), very much (1
point) and extremely (1 point). The total score of the
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from 0 to 9. Scores ≤3 points classify the patient as low risk.
Scores ≥4 points indicate the need to examine the psycho-
logical subscale comprised of questions 5 to 9. Patients with
scores ≤3 points on the psychological subscale are classified
as medium risk and patients with scores ≥4 are classified as
high risk. The SBST-Brazil was only used for screening and
not as an outcome measure instrument.Pain Numerical Rating Scale
The Pain Numerical Rating Scale is a scale of 11 points
(0–10) that aims to measure the intensity of pain re-
ported by the patient, where 0 = “no pain” and 10 = “pain
as bad as could be” [32]. In this study patients will be
asked about their pain intensity in the last 7 days.Patient-Specific Functional Scale
The Patient-specific Functional Scale provides reliable
measurements of limitations in specific tasks [32]. The pa-
tient is asked to choose three activities that they cannot
perform or can perform with difficulty because of pain.
Each activity is scored on a Likert scale that ranges from 0
(unable to perform the activity) to 10 (able to perform the
activity at preinjury level). The final result is the average of
the three scores from 0 to 10 points. High values indicate
a lower degree of limitation in performing specific tasks
[33, 34]. This questionnaire presents good responsiveness
with patients with low functional limitation [16].Oswestry Disability Index
The Oswestry Disability Index aims to assess disability
associated with low back pain [35, 36]. This question-
naire consists of 10 items describing everyday situations
that patients may find difficult to perform due to low
back pain. Each of the 10 items is scored from 0 to 5,
adding up to a maximum score of 50 points. The result
is multiplied by 2 to obtain a percentage. From this ob-
tained percentage it is possible to classify the patients as
having: minimal disability (0% to 20%), moderate disabil-
ity (20% to 40%), severe disability (40% to 60%), crippled
(60% to 80%) and bedridden (80% to 100%).Global Perceived Effect Scale
The Global Perceived Effect Scale seeks to evaluate clin-
ical changes perceived by the patient by comparing the
onset of symptoms to the current situation [32]. It is an
11-point grading scale (−5 to 5) wherein −5 = vastly
worse; 0 = no change; and 5 = completely recovered.
High scores indicate greater perceived recovery of the
condition [32]. This scale is more responsive with pa-
tients who have low functional limitation [16].Consultation and Relational Empathy – CARE
The Consultation and Relational Empathy (CARE)
Measure is a questionnaire to assess patients’ perception
of empathy and communication during consultation
[37–39]. It consists of 10 questions answered according
to a Likert scale of 1 to 5 (where 1 = poor and 5 = excel-
lent). The final score is obtained by adding the ques-
tions’ scores, with a maximum score of 50 and a
minimum score of 10 points. High values indicate
greater empathy. Each question contains a “not applic-
able” answer; in this case, the item must be excluded
and the result will be obtained from the average score of
the questions answered [37]. The questionnaire will be
applied by a blinded assessor after the first treatment
session.
Expectation and credibility
Improvement expectation will be assessed by a numer-
ical scale of 11 points, with 0 = “no expectation of im-
provement” and 10 = “the highest expectation of
improvement” [40]. Credibility regarding the treatment
will be evaluated by four questions. These questions in-
clude confidence-related issues that treatment can help
to ease and deal with pain, confidence in recommending
treatment to other patient and how much treatment
makes sense to the patient. These questions will be
scored according to a Likert scale ranging from 0 (no
confident) to 6 (totally confident) [40]. Expectation and
credibility will be evaluated after a week of
randomization.
Treatment protocol
Patients will be randomized into three groups: a Positive
Therapeutic Alliance (PTA) group, a Usual Treatment
(UT) group and a Control group (CG). Treatment ses-
sions will be conducted face-to-face and individually
with each patient. The treatment sessions will be deliv-
ered by two physical therapists with postgraduate quali-
fications and a completed Master’s degree in the
research field.
The treatment protocol offered to the PTA and UT
groups will be based on research that demonstrates the
effectiveness of empathy and communication training
with patients [26–28, 41]. Patients in the PTA and UT
groups will receive two 60-min treatment sessions with
a 1-week interval. The sessions will be held in an ordin-
ary physical therapy office following the standards of
comfort, organization and hygiene. The treatment proto-
col is initially structured in education and differentiation
regarding the nonverbal behavior of the therapist and
key issues related to the treatment. In order to ensure
treatment fidelity, and to standardize the information
that will be provided to patients in both groups, the
therapists will follow a description of the relevant issues
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treatment protocol recommendations were developed
based on previous studies and designed to ensure the
enhancement of the therapeutic alliance in one group
and reduce it in the other [26–28, 41]. Considering the
type of intervention, the therapists will not need any
physical or informational materials to deliver the inter-
vention. It is important to emphasize that the PTA and
UT groups will receive the same informational content
related to low back pain. The difference will be the form
used to transmit this information.
The patients in the PTA group will undergo an inter-
vention based on treatment guidelines involving guid-
ance and information related to a return to daily
activities, advice on dealing with the pain and clear ex-
planation of their signs and symptoms [9, 18, 42, 43].
The sessions will be structured with the intention of in-
creasing therapeutic alliance and empathy, based on
topics relating to the condition and behavior taken from
The Back Book [43]. UT-group patients will also receive
the same informational content on low back pain based
on The Back Book [43]. Therapy sessions will be per-
formed with limited interaction between patient andTable 2 Topics to be addressed during therapy in Positive Therapeu
Addressed topic Key issues to be discussed
Regarding low back pain • Low back pain causes
• Low back pain diagnosis
• Low back pain classification
• Prognosis
• Low back pain natural history
Imaging tests • Imaging findings in asymptomatic peopl
• Normal degenerative signs
Physical activity and Rest • The importance of physical activity
• Low back pain behavior
Pain control • Medication
• Available treatments
• Self-care
Family and work, anxiety and
stress-related factors
• The importance of family support
• The importance of controlling anxiety
and stress
• The influence of these factors on back p
Concepts of chronic pain • Current concept of pain
• Pain threshold
• Central hypersensitivity
Encouragement 51,55 • Good prognosis: subgroup of low risk
of involvement of psychosocial factors
• Return to activitiestherapist and the information will be transmitted in a clear
and straightforward manner [23]. Patients in the CG will
not receive any treatment and will be instructed not to seek
treatment for the first month after randomization. The
treatment offered to the PTA or UTgroups will be available
for patients who are interested after a period of 1 year. Pa-
tients will not be limited in looking for other types of treat-
ment after the first month and will be evaluated at baseline
and during every reassessment. Since patients will be re-
cruited from a waiting list and will receive the care offered
in this study after 1 year, we believe that this conduct does
not violate any ethical principles with these patients.
Patients who require additional interventions other than
those offered by this study will be referred for treatment at
teaching clinics of the participating universities. Patients’ use
of medication will not be limited and will be controlled at
each reassessment. Patients will be advised not to seek other
treatment options during the intervention period. Patients
will not receive any financial compensation for participation.
Statistical analysis
A researcher not involved in data collection and without
any conflict of interest will be responsible for monitoringtic Alliance and Usual Treatment Groups [9, 27, 41–43, 47–54]
Example sentences
“Permanent or severe back damages are rare”
“It is really very difficult to damage your back”
“Back pain is rarely caused by a serious illness”
“Back pain prognosis is favorable”
e “About 60% of the asymptomatic population has some sort of
degenerative sign”
“There is nothing seriously wrong in your back”
“The sooner you resume your activities the sooner you will
get better”
“Rest is not good for the back”
“You may have some limitations, but the most important thing
is to keep moving”
“There are several steps you can take to help your back pain”
“Physicians and physical therapists can help your back pain,
but only you are able to take care of yourself”
ain
“Gradually return to your social activities and work! The sooner
you return, the less future problems you will have”
“You really can help yourself!”
“People who cope better with the pain return to their activities
faster and better”
“You will have good and bad days, this is normal!”
“Although the natural history is positive, there are some factors
that contribute to pain that becomes chronic, we will work on
them”
“Pain does not mean back injury”
“Pain is a response to sensory stimuli, and it is not necessarily
related to any tissue damage in the spine”
“Pain can just be a misunderstanding of the body”
“This information is taken from the best and most current
research in the world”
“Do not let your back pain take over your life, you are able
to get through it”
Table 3 Guidelines for standard treatment sessions of the Positive Therapeutic Alliance Group [55–59]
Addressed aspect Description Key issues to approach
Appointment outset A warming and caring reception “Hello! I was waiting for you!”
“Apart from the pain, are you all right today?”
Demographic questions Show interest in getting to know the patient “I think I know your family name…”
“Tell me more about yourself”
Medical diagnosis Ask about patient’s condition in an interested
manner
“This part of the assessment interests me very much,
tell me about your condition, what did the physician
say?”
Primary complaint Demonstrate interest in the current complaint “In your daily routine, what bothers you the most?
What is your primary complaint? Tell me so I can help you.”
Clinical history Address issues about the patient’s condition
(beginning, development, current condition)
Inquire about medical history, involving other
issues, not only low back pain
“First, I have a few questions that will help me better
understand your pain”
Pain location Investigate and demonstrate an effort to
understand the patient’s pain complaint
“Use your hand to show me where your pain is”
“From this point, does this pain go up/down
or sideways?
Pain behavior Investigate and demonstrate an effort to
understand the patient’s pain complaint
“I am also interested in your personal symptoms”
“Does this pain change during the day?”
“Describe the pain to me”
“Which activity of your daily life makes the pain worse?”
Primary limited daily activity Question the patient demonstrating an interest
in a way to encourage a return to activities
“How did this pain affect your lifestyle?”
Session closure Reinforce positive messages “You did very well today! And certainly you will be fine”
“I understand that these chronic situations sometimes
get out of our control, but I am sure you will do well”
“No matter what happens. Try to be patient with
yourself and look for positive things that are
happening to you ”
Eye contact Maintain eye contact while listening to the patient -
Facial expressions in response
to patients’ questions
Demonstrate emotions through facial expression
Facilitate nonverbal communication through facial
clues
-
Posture Adopt a posture of attention, mutual respect and
receptivity
-
Tone of voice Use different tones of voice to emphasize the
importance or the focus on a particular subject
during treatment
-
Affection Demonstrate the importance of patient
participation in the therapeutic process




Address issues related to work, family and social
life
-
Shared decision making Share decision-making regarding treatment
Involve the patient in the healing context
“Shall we set some goals together in order to improve
your condition?”
Demonstration of empathy Reflect the emotions that patients present
Create an environment of comfort and
responsiveness
“Your back pain must be very hard for you”




Focus on information about the success of
treatment, based on the best available scientific
evidence
“The treatment being offered to you is scientifically
proven to be the most suitable for your case”
Personal experience Demonstrate successful experiences with
similar cases
“The clinical experience I have had with this new
treatment is promising! Often patients already feel
much better soon after the treatment”
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tients and assessors will be audited monthly by an expe-
rienced researcher. All data will be entered twice before
statistical procedures. A researcher who will receive the
data in an encrypted format to ensure confidentiality will
conduct the statistical analysis.
Linear mixed models will be used for primary analysis
to verify the differences between the average effects of in-
terventions in reassessments carried out 1 month,
6 months and 12 months after randomization. The differ-
ences between groups will be calculated by interaction
terms of groups versus time. The time will be coded as a
categorical variable (baseline, 1 month, 6 months and
12 months after randomization). No interim analysis will
be performed. The process of analysis of treatment effi-
cacy will follow the intention-to-treat analysis [44]. If a pa-
tient abandons treatment or refuses to answer any
reassessment, the lost data will not be replaced. All statis-
tical procedures will be performed with a significance level
of 5% and through the SPSS 19 software for Windows.
Discussion
The results of this study will help us to understand the ef-
fect of combining increased therapeutic alliance with a type
of treatment based on advice, information and advice for
patients with chronic low back pain and low risk of
psychosocial-factor involvement. We believe that the UT
group will present significantly better treatment results
when compared to the CG. Regarding the PTA group, the
study hypothesis is that: 1 month after randomization, there
will be a significant clinical decrease in pain and especially
in specific disability, when compared to the other two study
groups. This assumption is based on recent studies, which
have shown that the therapeutic alliance does in fact have a
positive influence on clinical outcomes of patients with ir-
ritable bowel syndrome [23], rehabilitation needs [21] and
chronic musculoskeletal disorders [29]. Treatment adher-
ence appears to be directly influenced by patients’ trust and
empathy with the health care professional. Thus, decreased
specific disability may occur because the patient follows the
guidelines provided by the health care professional with
more confidence. Our research group expects to publish
the results of this study in an internationally recognized
journal and to release the spreadsheet with the data
encoded during the first semester of 2018.
It is known that a minority of patients who develop
chronic pain are responsible for most of the treatment-
related costs [5, 6]. It is, therefore, important to identify
whether patients at low risk of psychosocial-factor in-
volvement respond positively to a minimal, effective and
inexpensive treatment intervention. To date, this study is
the largest randomized controlled trial involving the com-
bination of therapeutic alliance with minimal intervention
in patients with chronic, nonspecific low back pain. Theresults of this study may help the clinical practice of pro-
fessionals dealing with patients with chronic, nonspecific
low back. The health system can benefit from this type of
intervention, avoiding excessive or unnecessary diagnostic
investigations and treatments for these patients. This may
lead to cost reduction regarding medication, diagnostic
tests, consultations, treatments or absence from work.
Furthermore, the health care system could provide access
and opportunity for treatment for patients who require
more attention to symptom evaluation and treatment
(medium and high risk psychosocial-factor involvement).
In conclusion, there might be the possibility to reduce
waiting time for treatment, facilitating the flow and quality
of primary care for low-risk low-back-pain patients.
Trial status
Recruitment started in September 2015 and is expected
to continue until December 2016.
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